Work

Brief Communication: Personalized Circulating Tumor DNA as a Predictor of Pathologic Response in Neoadjuvant Treatment of Resectable Melanoma

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Immunotherapy

DOI: 10.1097/cji.0000000000000605

Authors: Justine V. Cohen, Mofei Liu, Grace Rogers, Michael Manos, Patricia McHugh, Ashley Schwer, Patrick A. Ott, Ann W. Silk, Karam Khaddour, Elizabeth I. Buchbinder, William J. Gibson, Frank Stephen Hodi, Hillary C. Tsibris

Institutions: Harvard University, Dana-Farber Cancer Institute, Brigham and Women's Hospital

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154459284

FWCI:

Cites: 14

Cited by:

Related to: